Technical Analysis for PEN - Penumbra, Inc.

Grade Last Price % Change Price Change
grade A 234.895 3.26% 7.43
PEN closed down 0.88 percent on Tuesday, August 4, 2020, on 2.0 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical PEN trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 3.26%
Slingshot Bullish Bullish Swing Setup 3.26%
Earnings Movers Other 3.26%
Overbought Stochastic Strength 3.26%
New 52 Week Closing High Bullish 2.36%
Pocket Pivot Bullish Swing Setup 2.36%
New 52 Week High Strength 2.36%
Upper Bollinger Band Walk Strength 2.36%
Above Upper BB Strength 2.36%
Overbought Stochastic Strength 2.36%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in United States, Japan, and internationally. The company offers neurovascular access products under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, PXSLIM, and Velocity brands; and aspiration-based thrombectomy systems and accessory devices under the Penumbra System brand, as well as stent retriever for mechanical thrombectomy under the 3D brand. It also provides neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands, as well as neurovascular stents under the LIBERTY Stent brand; neurosurgical tools for the removal of tissue and fluids under the Apollo System brand; detachable embolic coil systems for peripheral embolization under the RUBY Coil brand; detachable, microcatheter-deliverable occlusion devices under the POD (penumbra occlusion device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand. The company sells its products through its salesforce and distributors to hospitals in the neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Medicine Health Health Care Interventional Radiology Markets Medical Devices Stent Aneurysm

Is PEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 230.86
52 Week Low 121.8
Average Volume 248,607
200-Day Moving Average 172.82
50-Day Moving Average 187.50
20-Day Moving Average 205.08
10-Day Moving Average 217.04
Average True Range 7.64
ADX 36.23
+DI 33.98
-DI 15.86
Chandelier Exit (Long, 3 ATRs ) 207.94
Chandelier Exit (Short, 3 ATRs ) 205.22
Upper Bollinger Band 232.77
Lower Bollinger Band 177.40
Percent B (%b) 0.9
BandWidth 27.00
MACD Line 11.54
MACD Signal Line 9.40
MACD Histogram 2.1366
Fundamentals Value
Market Cap 7.69 Billion
Num Shares 33.8 Million
EPS 0.15
Price-to-Earnings (P/E) Ratio 1516.47
Price-to-Sales 11.15
Price-to-Book 8.79
PEG Ratio -71.69
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 249.58
Resistance 3 (R3) 247.31 237.66 245.90
Resistance 2 (R2) 237.66 232.03 238.80 244.67
Resistance 1 (R1) 232.57 228.55 235.12 234.84 243.44
Pivot Point 222.92 222.92 224.20 224.06 222.92
Support 1 (S1) 217.83 217.29 220.38 220.10 211.50
Support 2 (S2) 208.18 213.81 209.32 210.27
Support 3 (S3) 203.09 208.18 209.05
Support 4 (S4) 205.36